The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
about
Mechanism and significance of cell type-dependent neutralization of flavivirusesShake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostPossible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsRole of dendritic cells in antibody-dependent enhancement of dengue virus infectionExposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyBroadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeDegrees of maturity: the complex structure and biology of flavivirusesMouse models to study dengue virus immunology and pathogenesisDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesRational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesHow antibodies alter the cell entry pathway of dengue virus particles in macrophagesDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusInduction of Epitope-Specific Neutralizing Antibodies against West Nile VirusEpitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized AntibodyType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesComplement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerMaturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated NeutralizationHumanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In VivoCharacterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 VirusClosing the door on flaviviruses: Entry as a target for antiviral drug designThe structural immunology of antibody protection against West Nile virusMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentA Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within EndosomesWest Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier FunctionHuman Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment StepAntibodies against viruses: passive and active immunizationDevelopment of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile VirusComplement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanismProgress on the development of therapeutics against West Nile virusA Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever ModelComplement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile VirusProtonation of Individual Histidine Residues Is Not Required for the pH-Dependent Entry of West Nile Virus: Evaluation of the "Histidine Switch" HypothesisThe relationship of interacting immunological components in dengue pathogenesisMonoclonal antibody produced in plants efficiently treats West Nile virus infection in miceEnhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue DiseaseThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion IntermediateDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityStructural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
P2860
Q23032973-3187A048-50F1-46A8-81D1-18FE75C9E39CQ23925011-BA0D436C-6370-4D64-B9A0-C464CEA64330Q24289014-BD21B228-338C-4BBD-B2FA-EC02F36DBED9Q24655655-66648C9A-3757-45B6-A152-109136180DDAQ24701766-CEBD6D3B-7C1F-4F3D-B349-75983AB159A8Q26252060-AE3A79BB-F583-4BB4-9775-B35FF9304981Q26824712-EBBA8E5E-3463-4203-83AF-6AB1745442C7Q27010151-53318E1E-5AB0-41E1-8D0B-587C2A975206Q27304342-CB48EA01-FCD9-4C56-8574-42E1904C2BCEQ27334248-41ED52D2-C817-4726-BFD7-909A008AD97FQ27334575-52040731-28DF-422B-8AA1-7D19179EAB34Q27335008-5FD1C3D8-B423-4EE3-ACE6-B81C7C75009CQ27484980-5184C4F7-14D4-4AEC-B05C-B144E6C8C96BQ27485025-8542B373-45A1-4C6D-9A7D-CE0CA6A689F7Q27485031-BC6FD5F2-7FB0-425C-AE90-49E897569F40Q27485131-BC611F77-D736-4166-A7AD-F46F2799C864Q27485890-3B3B655B-8CAC-4A7B-9A2A-ED5F82FD6C46Q27486404-F7030E5D-ED88-41C9-A3BB-A4021325DF61Q27486788-6494B303-1A82-4D61-98F5-C778963B5F1CQ27487953-48CFE19E-C002-4840-A691-448B6A48CA25Q27487955-EBB908E5-BA2B-4EAB-9267-CD6471A2C4ABQ27488337-254269A8-C7BC-4E92-8ABF-B928D0932B77Q27488364-66F484A5-0076-4E53-A363-153BD94853C0Q27488367-FE656D6E-3A44-4FB2-B419-DB0E17F76E17Q27488431-5F1FF0A8-CCFC-49E6-8A12-08D6C4F230B2Q27488791-FAEDFFAC-DCF2-4D96-8D7F-9FF0C2563336Q27489392-5F417E90-D9FA-4E60-A941-2303DDAB7AF1Q27489782-71856C3E-558D-4AAF-9ACA-ABD284F15E23Q27489809-246A2DF5-7FE4-43B3-BBF6-E87D8294137BQ27489893-EA1BD8E8-08E7-4735-909B-5F75392B8A87Q27490166-E7A630AB-28C6-423D-BAEF-7F8DB28587C9Q27490423-6588384C-0DE8-4AA5-A74A-7A3E9D99EF1DQ27490468-144C0123-8403-4B91-BDFC-0E08E9369770Q27490496-53B019C6-8522-426E-AD8A-1F395BFE1B72Q27490937-6A8AA080-B0B0-44A5-AD88-48F22BD5AF28Q27490947-C431D2A8-8106-42F8-8DE3-0B9319522904Q27491317-888001DB-C125-47D5-9000-35664B4D7FEEQ27491339-354BD528-6C65-4564-8071-8F1078C00EDFQ27654848-D295E838-6F42-4BDE-A9EA-8CFDF8FCE9C3Q27674417-488B1992-FC1B-43B5-802B-ECC51A3FFFD1
P2860
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@ast
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@en
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@nl
type
label
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@ast
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@en
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@nl
prefLabel
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@ast
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@en
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
The Stoichiometry of Antibody- ...... t of West Nile Virus Infection
@en
P2093
Daved H Fremont
Grant E Nybakken
Steevenson Nelson
P2860
P304
P3181
P356
10.1016/J.CHOM.2007.03.002
P5008
P577
2007-04-19T00:00:00Z